Skip to content
Home
Services
Areas of Expertise
Healthcare & Lifesciences
Corporate
Mergers & Acquisitions
Technology & Data
Our People
Insights
Insights
News
Why AI Companies Should Be Worrying About Thomson Reuters v. Ross
March 11, 2025
A Closer Look: India’s Draft Digital Personal Data Protection Rules
January 9, 2025
OpenAI’s Seeks to Consolidate Copyright Lawsuits: A Closer Look
December 19, 2024
Read All Insights
Quoted in Scroll.In:
News 18.com: Jab of Indemnity
News 18.com: Trips Waiver
Read All News
Home
Services
Areas of Expertise
Healthcare & Lifesciences
Corporate
Mergers & Acquisitions
Technology & Data
Our People
Insights
Insights
News
Why AI Companies Should Be Worrying About Thomson Reuters v. Ross
March 11, 2025
A Closer Look: India’s Draft Digital Personal Data Protection Rules
January 9, 2025
OpenAI’s Seeks to Consolidate Copyright Lawsuits: A Closer Look
December 19, 2024
Read All Insights
Quoted in Scroll.In:
News 18.com: Jab of Indemnity
News 18.com: Trips Waiver
Read All News
Contact us
Home
Services
Healthcare And Lifesciences
Corporate
Mergers & Acquisitions
Technolgy and Data
Our People
Insights
News
Home
Services
Healthcare And Lifesciences
Corporate
Mergers & Acquisitions
Technolgy and Data
Our People
Insights
News
Insights
All
Artificial Intelligence
Corporate
Healthcare & LifeSciences
Mergers & Acquisitions
Technology & Data
The Politics of President Biden’s Support for the TRIPS Waiver Proposal
Healthcare & LifeSciences
The Politics of President Biden’s Support for the TRIPS Waiver Proposal
•
May 9, 2021
Corporate Vaccination Camps: FAQs for Employers
Healthcare & LifeSciences
Corporate Vaccination Camps: FAQs for Employers
•
May 9, 2021
A Jab of Indemnity
Healthcare & LifeSciences
A Jab of Indemnity
•
May 7, 2021
How the Vax was Won | Part 2: Follow the Money
Healthcare & LifeSciences
How the Vax was Won | Part 2: Follow the Money
•
April 13, 2021
How the Vax was won: Intellectual Property and Access to Medicines in a Public Health Crisis
Healthcare & LifeSciences
How the Vax was won: Intellectual Property and Access to Medicines in a Public Health Crisis
•
March 5, 2021
Scroll Up
